Centre Leon Berard Researchers Update Current Data on Cancer (Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort).

MLA

“Centre Leon Berard Researchers Update Current Data on Cancer (Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort).” Clinical Trials Week, July 2023, p. 163. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=167379997&authtype=sso&custid=ns315887.

APA

Centre Leon Berard Researchers Update Current Data on Cancer (Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort). (2023). Clinical Trials Week, 163.

Chicago

“Centre Leon Berard Researchers Update Current Data on Cancer (Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort).” 2023. Clinical Trials Week, July, 163. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=167379997&authtype=sso&custid=ns315887.